Literature DB >> 18483194

MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression.

Frank E Erfurth1, Relja Popovic, Jolanta Grembecka, Tomasz Cierpicki, Catherine Theisler, Zhen-Biao Xia, Tara Stuart, Manuel O Diaz, John H Bushweller, Nancy J Zeleznik-Le.   

Abstract

Homeobox (HOX) genes play a definitive role in determination of cell fate during embryogenesis and hematopoiesis. MLL-related leukemia is coincident with increased expression of a subset of HOX genes, including HOXA9. MLL functions to maintain, rather than initiate, expression of its target genes. However, the mechanism of MLL maintenance of target gene expression is not understood. Here, we demonstrate that Mll binds to specific clusters of CpG residues within the Hoxa9 locus and regulates expression of multiple transcripts. The presence of Mll at these clusters provides protection from DNA methylation. shRNA knock-down of Mll reverses the methylation protection status at the previously protected CpG clusters; methylation at these CpG residues is similar to that observed in Mll null cells. Furthermore, reconstituting MLL expression in Mll null cells can reverse DNA methylation of the same CpG residues, demonstrating a dominant effect of MLL in protecting this specific region from DNA methylation. Intriguingly, an oncogenic MLL-AF4 fusion can also reverse DNA methylation, but only for a subset of these CpGs. This method of transcriptional regulation suggests a mechanism that explains the role of Mll in transcriptional maintenance, but it may extend to other CpG DNA binding proteins. Protection from methylation may be an important mechanism of epigenetic inheritance by regulating the function of both de novo and maintenance DNA methyltransferases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483194      PMCID: PMC2396713          DOI: 10.1073/pnas.0800090105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Methyl-CpG-binding proteins. Targeting specific gene repression.

Authors:  E Ballestar; A P Wolffe
Journal:  Eur J Biochem       Date:  2001-01

2.  MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein.

Authors:  P Ernst; J Wang; M Huang; R H Goodman; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation.

Authors:  Marco Birke; Silke Schreiner; María-Paz García-Cuéllar; Kerstin Mahr; Fritz Titgemeyer; Robert K Slany
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

4.  Identification and characterization of the DNA binding domain of CpG-binding protein.

Authors:  J H Lee; K S Voo; D G Skalnik
Journal:  J Biol Chem       Date:  2001-09-25       Impact factor: 5.157

5.  Protein binding protects sites on stable episomes and in the chromosome from de novo methylation.

Authors:  L Han; I G Lin; C L Hsieh
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

6.  The DNMT1 target recognition domain resides in the N terminus.

Authors:  F D Araujo; S Croteau; A D Slack; S Milutinovic; P Bigey; G B Price; M Zannis-Hadjopoulos; M Zannis-Hajopoulos; M Szyf
Journal:  J Biol Chem       Date:  2000-12-04       Impact factor: 5.157

7.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

8.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.

Authors:  Scott A Armstrong; Jane E Staunton; Lewis B Silverman; Rob Pieters; Monique L den Boer; Mark D Minden; Stephen E Sallan; Eric S Lander; Todd R Golub; Stanley J Korsmeyer
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

9.  MLL targets SET domain methyltransferase activity to Hox gene promoters.

Authors:  Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

10.  Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.

Authors:  Adolfo A Ferrando; Scott A Armstrong; Donna S Neuberg; Stephen E Sallan; Lewis B Silverman; Stanley J Korsmeyer; A Thomas Look
Journal:  Blood       Date:  2003-03-13       Impact factor: 22.113

View more
  50 in total

1.  Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?

Authors:  Tim C P Somervaille; Michael L Cleary
Journal:  Int J Hematol       Date:  2010-05-08       Impact factor: 2.490

2.  Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability.

Authors:  Daniel Cortázar; Christophe Kunz; Jim Selfridge; Teresa Lettieri; Yusuke Saito; Eilidh MacDougall; Annika Wirz; David Schuermann; Angelika L Jacobs; Fredy Siegrist; Roland Steinacher; Josef Jiricny; Adrian Bird; Primo Schär
Journal:  Nature       Date:  2011-01-30       Impact factor: 49.962

3.  Ex vivo expansion of cord blood progenitors impairs their short-term and long-term repopulating activity associated with transcriptional dysregulation of signalling networks.

Authors:  T Holmes; F Yan; K-H Ko; R Nordon; E Song; T A O'Brien; A Dolnikov
Journal:  Cell Prolif       Date:  2012-03-20       Impact factor: 6.831

Review 4.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

5.  Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.

Authors:  Laurie E Risner; Aravinda Kuntimaddi; Alyson A Lokken; Nicholas J Achille; Noah W Birch; Kelly Schoenfelt; John H Bushweller; Nancy J Zeleznik-Le
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 6.  The pathogenesis of mixed-lineage leukemia.

Authors:  Andrew G Muntean; Jay L Hess
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

7.  The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands.

Authors:  Hideyuki Takeshima; Satoshi Yamashita; Taichi Shimazu; Tohru Niwa; Toshikazu Ushijima
Journal:  Genome Res       Date:  2009-08-03       Impact factor: 9.043

8.  DNA methylation is a guardian of stem cell self-renewal and multipotency.

Authors:  Laurraine-Marcelle Gereige; Hanna K A Mikkola
Journal:  Nat Genet       Date:  2009-11       Impact factor: 38.330

9.  Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.

Authors:  Tomasz Cierpicki; Laurie E Risner; Jolanta Grembecka; Stephen M Lukasik; Relja Popovic; Monika Omonkowska; David D Shultis; Nancy J Zeleznik-Le; John H Bushweller
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

10.  Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.

Authors:  Relja Popovic; Laurie E Riesbeck; Chinavenmeni S Velu; Aditya Chaubey; Jiwang Zhang; Nicholas J Achille; Frank E Erfurth; Katherine Eaton; Jun Lu; H Leighton Grimes; Jianjun Chen; Janet D Rowley; Nancy J Zeleznik-Le
Journal:  Blood       Date:  2009-02-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.